Morphological cell profiling of SARS-CoV-2 infection identifies drug repurposing candidates for COVID-19Carmen Mirabelli, Jonathan Z. Sexton|Proceedings of the National Academy of Sciences|2021Cited by 199
Morphological Cell Profiling of SARS-CoV-2 Infection Identifies Drug Repurposing Candidates for COVID-19Carmen Mirabelli, Jonathan Z. Sexton|bioRxiv (Cold Spring Harbor Laboratory)|2020Cited by 102
Proxalutamide reduces SARS-CoV-2 infection and associated inflammatory responseYuanyuan Qiao, Arul M. Chinnaiyan, Carla D. Pretto et al.|Proceedings of the National Academy of Sciences|2023Cited by 8